The biological basis of chemoresistance in ALK + ALCL patients is incompletely understood, but a recent report [3] describing the existence of cancer stem-like cells (CSCs) raises the possibility that these cells may play a role, similar to how CSCs might contribute to chemoresistance and cancer relapses in other cancer models [4, 5]. The gene discussed is ALK; the disease is cancer.